@article{solas:inserm-02128507,
  TITLE = {{Ledipasvir and tenofovir drug interaction in human immunodeficiency virus-hepatitis C virus coinfected patients: Impact on tenofovir trough concentrations and renal safety}},
  AUTHOR = {Solas, Caroline and Bregigeon, Sylvie and Faucher-Zaegel, Olivia and Quaranta, Sylvie and Obry-Roguet, Veronique and Tamalet, Catherine and Lacarelle, Bruno and Poizot-Martin, Isabelle},
  URL = {https://inserm.hal.science/inserm-02128507},
  JOURNAL = {{British Journal of Clinical Pharmacology}},
  PUBLISHER = {{Wiley}},
  VOLUME = {84},
  NUMBER = {2},
  PAGES = {404-409},
  YEAR = {2018},
  MONTH = Feb,
  DOI = {10.1111/bcp.13450},
  KEYWORDS = {drug-drug interaction ; human immunodeficiency virus-hepatitis C virus coinfection ; ledipasvir ; renal function ; tenofovir},
  PDF = {https://inserm.hal.science/inserm-02128507/file/Solas_et_al-2018-British_Journal_of_Clinical_Pharmacology.pdf},
  HAL_ID = {inserm-02128507},
  HAL_VERSION = {v1},
}